ASX - By Stock
|
RFT |
Re:
Ann: Suspension from Quotation
|
|
jklotto
|
86 |
24K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
86
|
24K
|
1
|
|
ASX - By Stock
|
RFT |
Re:
Ann: Suspension from Quotation
|
|
jklotto
|
86 |
24K |
7 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
86
|
24K
|
7
|
|
ASX - By Stock
|
SEN |
Re:
Ann: NON-RENOUNCEABLE RIGHTS OFFER AND INSTITUTIONAL PLACEMENT
|
|
jklotto
|
14 |
4.9K |
6 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
14
|
4.9K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Chairman's Address and Investor Presentation
|
|
jklotto
|
75 |
24K |
8 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
75
|
24K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD US reimbursement price & Aus regulatory decision
|
|
jklotto
|
17 |
8.1K |
16 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
17
|
8.1K
|
16
|
|
ASX - By Stock
|
RFT |
Re:
Why would you sell a good story > new episode
|
|
jklotto
|
25 |
7.2K |
4 |
24/09/23 |
24/09/23 |
ASX - By Stock
|
25
|
7.2K
|
4
|
|
ASX - By Stock
|
PIQ |
Australasian Diabetes Congress
|
|
jklotto
|
0 |
450 |
7 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
0
|
450
|
7
|
|
ASX - By Stock
|
RFT |
Re:
Ann: Preliminary Final Report
|
|
jklotto
|
154 |
34K |
4 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
154
|
34K
|
4
|
|
ASX - By Stock
|
RFT |
Re:
RE RATINGS or Dividends\
|
|
jklotto
|
19 |
3.8K |
4 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
19
|
3.8K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jklotto
|
16 |
7.2K |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
16
|
7.2K
|
2
|
|
ASX - By Stock
|
ESK |
Re:
Ann: CEO presentation to Annual General Meeting
|
|
jklotto
|
4 |
2.5K |
3 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
4
|
2.5K
|
3
|
|
ASX - By Stock
|
RFT |
Re:
Ann: Tritium Exclusive Supply Agreement
|
|
jklotto
|
166 |
54K |
3 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
166
|
54K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: New endometriosis test presented at international conference
|
|
jklotto
|
17 |
9.6K |
7 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
17
|
9.6K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
jklotto
|
11 |
4.2K |
5 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
11
|
4.2K
|
5
|
|
ASX - By Stock
|
RFT |
Re:
looking good
|
|
jklotto
|
104 |
32K |
8 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
104
|
32K
|
8
|
|
ASX - By Stock
|
DEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jklotto
|
15 |
6.1K |
5 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
15
|
6.1K
|
5
|
|
ASX - By Stock
|
AMT |
Re:
Ann: Company Update Correction
|
|
jklotto
|
5 |
1.6K |
1 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
5
|
1.6K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Letter of intent with Sonic Healthcare USA extended
|
|
jklotto
|
24 |
9.0K |
7 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
24
|
9.0K
|
7
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Quarterly Cash Flows and Activities Statement
|
|
jklotto
|
4 |
2.7K |
3 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
4
|
2.7K
|
3
|
|
ASX - By Stock
|
DEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jklotto
|
15 |
6.1K |
5 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
15
|
6.1K
|
5
|
|
ASX - By Stock
|
SBW |
Re:
News: SBW Shekel Brainweigh Says It Is On Track For Revenue Of $7.5 Mln In Q4
|
|
jklotto
|
7 |
2.0K |
2 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
7
|
2.0K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: CPT PLA reimbursement code approved in US for PromarkerD
|
|
jklotto
|
42 |
19K |
12 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
42
|
19K
|
12
|
|
ASX - By Stock
|
RFT |
Re:
Video
|
|
jklotto
|
21 |
7.3K |
2 |
17/12/22 |
17/12/22 |
ASX - By Stock
|
21
|
7.3K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: UK NICE publishes Medtech Innovation Briefing on PromarkerD
|
|
jklotto
|
7 |
4.3K |
6 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
7
|
4.3K
|
6
|
|
ASX - By Stock
|
RFT |
Re:
Ann: Product Purchase Orders from i-charging
|
|
jklotto
|
85 |
29K |
3 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
85
|
29K
|
3
|
|
ASX - By Stock
|
SEN |
Re:
Ann: Votiro Business Update Investor Webcast Presentation
|
|
jklotto
|
35 |
11K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
35
|
11K
|
2
|
|
ASX - By Stock
|
SEN |
Re:
Ann: Votiro Business Update Investor Webcast Presentation
|
|
jklotto
|
35 |
11K |
4 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
35
|
11K
|
4
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan Imaging Acquires Intellectual Property
|
|
jklotto
|
17 |
5.2K |
14 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
17
|
5.2K
|
14
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Appendix 4E and 2022 Annual Report
|
|
jklotto
|
5 |
2.9K |
8 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
5
|
2.9K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs binding LOI with Sonic Healthcare USA
|
|
jklotto
|
56 |
23K |
3 |
24/09/22 |
24/09/22 |
ASX - By Stock
|
56
|
23K
|
3
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - $15M Strategic Investment and Collaboration
|
|
jklotto
|
39 |
15K |
2 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
39
|
15K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Argus launch article
|
|
jklotto
|
9 |
4.2K |
6 |
11/09/22 |
11/09/22 |
ASX - By Stock
|
9
|
4.2K
|
6
|
|
ASX - By Stock
|
MX1 |
Re:
Argus launch article
|
|
jklotto
|
9 |
4.2K |
4 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
9
|
4.2K
|
4
|
|
ASX - By Stock
|
RFT |
Re:
Tritium Supply Order Progress
|
|
jklotto
|
31 |
11K |
0 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
31
|
11K
|
0
|
|
ASX - By Stock
|
RFT |
Re:
Tritium Supply Order Progress
|
|
jklotto
|
31 |
11K |
0 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
31
|
11K
|
0
|
|
ASX - By Stock
|
SEN |
Re:
Ann: Full Year Results Investor Presentation
|
|
jklotto
|
31 |
11K |
2 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
31
|
11K
|
2
|
|
ASX - By Stock
|
SEN |
Re:
Ann: Full Year Results Investor Presentation
|
|
jklotto
|
31 |
11K |
3 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
31
|
11K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs binding LOI with Sonic Healthcare USA
|
|
jklotto
|
56 |
23K |
11 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
56
|
23K
|
11
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Michael Aldridge Resigns as CEO, Remains as Director
|
|
jklotto
|
18 |
6.1K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
18
|
6.1K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Quarterly Cash Flows and Activities Statement
|
|
jklotto
|
17 |
8.3K |
3 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
17
|
8.3K
|
3
|
|
ASX - By Stock
|
OIL |
Re:
Share movements
|
|
jklotto
|
24 |
7.6K |
4 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
24
|
7.6K
|
4
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - DHS Checkpoint Design milestone achieved
|
|
jklotto
|
19 |
9.9K |
3 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
19
|
9.9K
|
3
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - DHS Checkpoint Design milestone achieved
|
|
jklotto
|
19 |
9.9K |
1 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
19
|
9.9K
|
1
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Phase II Results
|
|
jklotto
|
140 |
33K |
1 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
140
|
33K
|
1
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Phase II Preliminary Results
|
|
jklotto
|
62 |
21K |
3 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
62
|
21K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
jklotto
|
3.3K |
1.4M |
22 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
3.3K
|
1.4M
|
22
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
jklotto
|
1.0K |
431K |
13 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
1.0K
|
431K
|
13
|
|
ASX - By Stock
|
SEN |
Re:
Ann: Trading halt
|
|
jklotto
|
47 |
12K |
4 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
47
|
12K
|
4
|
|
ASX - By Stock
|
RFX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jklotto
|
11 |
5.1K |
6 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
11
|
5.1K
|
6
|
|
ASX - By Stock
|
HXL |
Re:
Interview with Michael Adridge
|
|
jklotto
|
6 |
2.3K |
0 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
6
|
2.3K
|
0
|
|